 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Gentherm Incorporated (THRM) designs, develops, and manufactures thermal management technologies and cable systems worldwide.
It operates through three segments: Climate Controlled Seats (CCS), Advanced Technology, and W.E.T.
The CCS segment offers products with variable temperature seat climate control systems for individualized thermal comfort to automobile passengers. It also provides automotive heated and cooled cup holders, and heated and cooled mattress products. This segment sells its products primarily to automobile and light truck original equipment manufacturers (OEMs), or their tier one suppliers.
The Advanced Technology segment is engaged in the advanced research and development activities to improve the efficiency of thermoelectric devices and to develop, market, and distribute products based on these new technologies.
The W.E.T. segment manufactures automotive seat comfort systems, specialized automotive cable systems, and other non-automotive product solutions. Its automotive seat comfort products include automotive seat heaters, climate comfort systems, and steering wheel heater systems, as well as integrated electronic components, such as blowers and electronic control units; and specialized automotive cable systems products consist of ready-made wire harnesses and related wiring products. This segment serves passenger car OEMs, commercial vehicle OEMs, and Tier 1 seat manufacturers, as well as the telecommunication, information technology, and medical equipment industries.
Shares have formed a bullish "cup & handle" after the firm reported strong 4Q results. Fourth-quarter earnings more than tripled to 31 cents per share, beating by 6 cents. Revenue climbed 23% to $182.3 million, topping projections for $168.4 million. The company also sees 2014 revenue increasing 10%-15% from 2013's total of $662 million, better than consensus of analysts for an 8.2% rise.
52-Week Trading Range: $13.63 - $33.02
Entry Point: $32.25
Stop Loss: $30.64
Target Price: $35.48
We are locking profits on THRM as we expect a market sell-off in the next few days. THRM closed at $34.89.
